olopatadine HCL 665 MCG/ACTUAT / mometasone furoate 25 MCG/ACTUAT Metered Dose Nasal Spray

RxCUI: 2591806
RxNorm name: olopatadine HCL 665 MCG/ACTUAT / mometasone furoate 25 MCG/ACTUAT Metered Dose Nasal Spray
Display name: olopatadine HCL 665 MCG/ACTUAT / mometasone furoate 25 MCG/ACTUAT Metered Dose Nasal Spray
Full name: olopatadine HCL 665 MCG/ACTUAT / mometasone furoate 25 MCG/ACTUAT Metered Dose Nasal Spray
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ryaltris	OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE	Glenmark Pharmaceuticals Inc., USA	406be932-f00e-4c66-9dd1-c142090fe822	2026-07-21	Warnings, Adverse reactions	Exact identifier rxcui: 2591806
Ryaltris	OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE	HIKMA SPECIALTY USA INC.	382eac74-a7ce-4f42-ac0a-b253308f335f	2026-01-23	Warnings, Adverse reactions	Exact identifier rxcui: 2591806

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
382eac74-a7ce-4f42-ac0a-b253308f335f	olopatadine HCL 665 MCG/ACTUAT / mometasone furoate 25 MCG/ACTUAT Metered Dose Nasal Spray [PSN] · mometasone furoate 0.025 MG/ACTUAT / olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray [SCD]	2	9	These highlights do not include all the information needed to use RYALTRIS ® safely and effectively. See full prescribing information for RYALTRIS. RYALTRIS (olopatadine hydrochloride and mometasone furoate monohydrate nasal spray) Initial U.S. Approval: 2022	20260123
406be932-f00e-4c66-9dd1-c142090fe822	olopatadine HCL 665 MCG/ACTUAT / mometasone furoate 25 MCG/ACTUAT Metered Dose Nasal Spray [PSN] · mometasone furoate 0.025 MG/ACTUAT / olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray [SCD]	2	1	These highlights do not include all the information needed to use RYALTRIS ® safely and effectively. See full prescribing information for RYALTRIS. RYALTRIS (olopatadine hydrochloride and mometasone furoate monohydrate nasal spray) Initial U.S. Approval: 2022	20260317